Nanophase Technologies Corporation (PK:NANX)
Business Focus: Specialty Chemicals
| Sector: Basic Materials | Industry: Specialty Chemicals |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 1319 MARQUETTE DRIVE ROMEOVILLE IL 60446 |
| Tel: | N/A |
| Website: | nanophase.com |
| IR: | See website |
| Key People | ||
| Rebecca Janet Whitmore Chairman of the Board | Jess A. Jankowski President, Chief Executive Officer, Chief Financial Officer, Director | |
| Business Overview |
| Nanophase Technologies Corporation is engaged in minerals-based and scientifically driven healthcare solutions across beauty and life science categories. The Company offers soup-to-nuts production, from engineered materials, formulation development, and finished product development, to commercial manufacturing and packaging capabilities. Its capabilities in materials engineering allow it to coat and disperse materials on a nano and non-nano scale for use in a variety of markets in skin health, including for use in sunscreens as active pharmaceutical ingredients (APIs) and as fully developed skincare products, marketed and sold through its wholly owned subsidiary, Solesence, LLC. The Company manufactures and supplies metric tons of surface-engineered zinc oxide and titanium dioxide to its customers, and these are used by major global consumer products companies for sunscreens and skin health-focused personal care products. It also manufactures and sells advanced nanoparticle materials. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Nanophase Technologies Corporation revenues remained flat at $37.3M. Net loss increased 67% to $4.4M. Revenues reflect Solésence segment increase of 9% to $25.2M, also reflect Personal Care Ingredients segment decrease of 17% to $9.3M, Advanced Materials segment decrease of 9% to $2.8M. Higher net loss reflects Research and development expense increase of 26% to $3.8M (expense). |
| Employees: | 79 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $67.73M as of Mar 31, 2024 |
| Annual revenue (TTM): | $37.30M as of Mar 31, 2024 |
| EBITDA (TTM): | -$2.80M as of Mar 31, 2024 |
| Net annual income (TTM): | -$4.39M as of Mar 31, 2024 |
| Free cash flow (TTM): | -$3.06M as of Mar 31, 2024 |
| Net Debt Last Fiscal Year: | $9.09M as of Mar 31, 2024 |
| Shares outstanding: | 54,801,834 as of Mar 28, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.